Pathalys Pharma
NC - RaleighPharmaceutical
Focus: Pathalys Pharma is a nephrology-focused pharmaceutical company developing treatments for chronic kidney disease (CKD) and related complications. The company is a Series B-stage biotech operating from Raleigh, NC with a concentrated pipeline in secondary hyperparathyroidism.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Funding Stage
SERIES B
Open Jobs
0
About Pathalys Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Pathalys Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 3
Clinical Trials (1)
NCT05836220Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Phase 3Help build intelligence for Pathalys Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.